A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease☆
Osaka University · Tokyo Yamate Medical Center · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
638
total citations
- FWCI
- 13.83
- Percentile
- 100%
- References
- 26
Citations per year
Authors
10Topics & keywords
Topics
Keywords
- Medicine
- Placebo
- Crohn's disease
- Regimen
- Internal medicine
- Gastroenterology
- Monoclonal antibody
- Clinical endpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.